Thomas D. Gilmore
Impact in
- Cancer Research top 0.1%
- NF-κB Signaling Pathways
- Immunology top 0.5%
- Immune Response and Inflammation
- interferon and immune responses
Papers in
-
- NF-κB Signaling Pathways 65
- Paleontology 17
- Marine Invertebrate Physiology and Ecology 17
- Co-authors
- Demetrios KalaitzidisNeil D. PerkinsGilles CourtoisGreg S. MartinFrancis S. WolenskiYuan WangHoward M. TeminPatrice J. Morin
- Journals
- Oncogene (21 papers)Molecular and Cellular Biology (12 papers)Journal of Virology (7 papers)Cancer Letters (5 papers)Cell (4 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Thomas D. Gilmore
156 papers receiving 12.0k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Cancer Research 4.5k
- Immunology 3.9k
- Molecular Biology 6.7k
- Oncology 2.2k
- Toxicology 234
Countries citing papers authored by Thomas D. Gilmore
This map shows the geographic impact of Thomas D. Gilmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Gilmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Gilmore more than expected).
Fields of papers citing papers by Thomas D. Gilmore
This network shows the impact of papers produced by Thomas D. Gilmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Gilmore. The network helps show where Thomas D. Gilmore may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas D. Gilmore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 31 | |
| 7 | 2019 | 9 | |
| 8 | 2013 | 51 | |
| 9 | 2012 | 27 | |
| 10 | 2009 | 24 | |
| 11 | 2009 | 20 | |
| 12 | 2006 | 417 | |
| 13 | 2005 | 314 | |
| 14 | 2004 | 9 | |
| 15 | 2003 | 128 | |
| 16 | 2003 | 40 | |
| 17 | 2002 | 89 | |
| 18 | 2001 | 19 | |
| 19 | 2001 | 1 | |
| 20 | 1981 | 32 |
About Thomas D. Gilmore
Thomas D. Gilmore is a scholar working on Cancer Research, Paleontology, Biotechnology, Immunology and Molecular Biology, having authored 157 papers that have together received 12.4k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (65 papers), Marine Invertebrate Physiology and Ecology (17 papers), Marine Sponges and Natural Products (17 papers), Cytokine Signaling Pathways and Interactions (16 papers), Natural product bioactivities and synthesis (15 papers), Immune Response and Inflammation (15 papers), interferon and immune responses (14 papers) and Virus-based gene therapy research (12 papers). The work is most often cited by research in Cancer Research (4.5k citations), Immunology (3.9k citations), Molecular Biology (6.7k citations), Oncology (2.2k citations) and Toxicology (234 citations). Thomas D. Gilmore has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Demetrios Kalaitzidis, Neil D. Perkins, Gilles Courtois, Greg S. Martin, Francis S. Wolenski, Yuan Wang, Howard M. Temin, Patrice J. Morin, John R. Regan and Pier F. Cirillo. Their work appears in journals such as Oncogene, Molecular and Cellular Biology, Journal of Virology, Cancer Letters and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.